or Try an Advanced Search...

    Technical Analysis for SRDX - SurModics, Inc.

    Grade Last Price % Change Price Change
    B 39.17 -0.05% -0.02
    SRDX closed down 0.05 percent on Wednesday, November 20, 2024, on approximately normal volume. Note that the stock is in overbought territory based on its Slow Stochastic indicator (14, 3, 3) -- so don't be surprised if it goes sideways or a pulls back.
    0 Watchers
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Weak or Absent Up Up Up
    Historical SRDX trend table...
    Date Alert Name Type % Chg
    20 DMA Support Bullish -6.83%
    Bollinger Band Squeeze Range Contraction -6.83%
    Narrow Range Bar Range Contraction -6.83%
    20 DMA Support Bullish -6.67%
    Bollinger Band Squeeze Range Contraction -6.67%
    Narrow Range Bar Range Contraction -6.67%
    Three Weeks Tight Range Contraction -6.67%
    20 DMA Support Bullish -6.69%
    Bollinger Band Squeeze Range Contraction -6.69%
    Narrow Range Bar Range Contraction -6.69%
    Older End-of-Day Signals for SRDX ...

       Recent Intraday Alerts

    Alert Time
    No Alerts Yet. Alerts will only show here if at least one person is tracking alerts on this stock.
    View Earlier Intraday Alerts

    Get a Trading Sidekick!

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Get Started for Free!
    Configure default chart indicators
    SRDX Chart by TradingView
    Basic chart:

    Profile

    SurModics, Inc. Description

    SurModics, Inc. provides drug delivery and surface modification technologies to the healthcare industry. The company offers surface modification coating technologies to enhance access, deliverability, and predictable deployment of medical devices, as well as drug delivery coating technologies to provide site-specific drug delivery from the surface of a medical device for the coronary, peripheral, neuro-vascular, urology, and other markets. It also provides in vitro diagnostic component products and technologies comprising protein stabilization reagents, substrates, polymers and reagent chemicals, antigens, and surface coatings for diagnostic test kits and biomedical research applications. SurModics, Inc. markets its technologies and products worldwide through direct sales force consisting of sales professionals. The company was founded in 1979 and is headquartered in Eden Prairie, Minnesota.

    Classification
    Sector: Healthcare
    Industry: Diagnostics & Research
    Keywords: Medical Equipment Polymers Urology Drug Delivery In Vitro Medical Research Component Products

    Is SRDX a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 3 bullish, 0 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    Nov 12 SurModics (SRDX) is an Incredible Growth Stock: 3 Reasons Why
    Nov 7 Surmodics Q4 Earnings and Revenues Beat Estimates, Margin Down
    Nov 6 Surmodics Non-GAAP EPS of -$0.13 beats by $0.16, revenue of $33.2M beats by $2.8M
    Nov 6 SurModics (SRDX) Reports Q4 Loss, Tops Revenue Estimates
    Nov 6 SurModics: Fiscal Q4 Earnings Snapshot
    Nov 6 Surmodics Reports Fourth Quarter and Fiscal Year 2024 Financial Results
    Oct 30 Surmodics Announces Early Results from PROWL Registry Study of Real-World Limb Ischemia Patients Treated with Pounce™ Thrombectomy System
    Oct 2 SRDX Stock Down Despite FDA Clearance for Pounce XL System
    Oct 1 Surmodics receives FDA clearance for its thrombectomy system
    Oct 1 Surmodics Receives FDA 510(k) Clearance for Pounce™ XL Thrombectomy System, Expanding the Pounce Thrombectomy Platform to Larger Peripheral Arteries up to 10 mm in Diameter
    See more SRDX news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 42.44
    52 Week Low 25.17
    Average Volume 223,390
    200-Day Moving Average 36.27
    50-Day Moving Average 38.49
    20-Day Moving Average 38.19
    10-Day Moving Average 38.65
    Average True Range 0.48
    RSI (14) 63.37
    ADX 18.59
    +DI 26.58
    -DI 15.20
    Chandelier Exit (Long, 3 ATRs) 37.83
    Chandelier Exit (Short, 3 ATRs) 38.57
    Upper Bollinger Bands 39.35
    Lower Bollinger Band 37.04
    Percent B (%b) 0.92
    BandWidth 6.05
    MACD Line 0.17
    MACD Signal Line 0.00
    MACD Histogram 0.1661
    Fundamentals Value
    Market Cap 557.62 Million
    Num Shares 14.2 Million
    EPS 0.39
    Price-to-Earnings (P/E) Ratio 100.44
    Price-to-Sales 3.37
    Price-to-Book 3.82
    PEG Ratio 3.90
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 39.37
    Resistance 3 (R3) 39.35 39.28 39.33
    Resistance 2 (R2) 39.28 39.23 39.28 39.32
    Resistance 1 (R1) 39.22 39.20 39.25 39.24 39.31
    Pivot Point 39.15 39.15 39.16 39.15 39.15
    Support 1 (S1) 39.09 39.10 39.12 39.10 39.03
    Support 2 (S2) 39.02 39.07 39.02 39.02
    Support 3 (S3) 38.96 39.02 39.01
    Support 4 (S4) 38.97